Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for MEDGF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for MEDGF and 80,000+ other tickers.
See exactly how MEDGF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for MEDGF and 80,000+ other tickers.
Medacta Group SA is a global developer, manufacturer, and distributor of specialized orthopedic and neurosurgical medical devices. Its operations span Europe, North America, Asia-Pacific, and other international markets. The firm provides advanced solutions, such as personalized kinematic models and cutting-edge 3D planning tools, designed to support a wide array of surgical procedures, including those for the hip, knee, shoulder, spine, and sports-related injuries. Established in 1958, Medacta maintains its corporate headquarters in Castel San Pietro, Switzerland.
Medacta Group (OTCMKTS:MEDGF - Get Free Report) and Inspire Medical Systems (NYSE: INSP - Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, analyst recommendations, dividends and profitability. Earnings and Valuation This table compares Medacta
Medacta Group SA (MEDGF) Q2 2026 Sales/Trading Call Transcript
Medacta Group SA (MEDGF) Q4 2025 Earnings Call Transcript
Medacta Group SA (MEDGF) Q4 2025 Sales/Trading Call Transcript